United States · FDA National Drug Code directory
NEUPOGEN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55513-530_7cedb5f4-cfdd-46a5-836d-e5384c65a224
- Product NDC
- 55513-530
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Filgrastim
- Labeler
- Amgen, Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 19970519
- Source listing expiry
- 20271231
Source-listed ingredients
- FILGRASTIM — 300 ug/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 PACKAGE (55513-530-10) / 1 mL in 1 VIAL (55513-530-01) · 55513-530-10
- 10 VIAL in 1 PACKAGE (55513-530-20) / 1 mL in 1 VIAL (55513-530-01) · 55513-530-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →